Correlation Between Processa Pharmaceuticals and Mosaic Immunoengineerin

Can any of the company-specific risk be diversified away by investing in both Processa Pharmaceuticals and Mosaic Immunoengineerin at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Processa Pharmaceuticals and Mosaic Immunoengineerin into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Processa Pharmaceuticals and Mosaic Immunoengineering, you can compare the effects of market volatilities on Processa Pharmaceuticals and Mosaic Immunoengineerin and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Processa Pharmaceuticals with a short position of Mosaic Immunoengineerin. Check out your portfolio center. Please also check ongoing floating volatility patterns of Processa Pharmaceuticals and Mosaic Immunoengineerin.

Diversification Opportunities for Processa Pharmaceuticals and Mosaic Immunoengineerin

-0.34

Correlation Coefficient

Processa Pharmaceuticals  Mosaic Immunoengineerin

Very good diversification

The 3 months correlation between Processa and Mosaic is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Processa Pharmaceuticals and Mosaic Immunoengineering in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mosaic Immunoengineering and Processa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Processa Pharmaceuticals are associated (or correlated) with Mosaic Immunoengineerin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mosaic Immunoengineering has no effect on the direction of Processa Pharmaceuticals i.e., Processa Pharmaceuticals and Mosaic Immunoengineerin go up and down completely randomly.

Pair Corralation between Processa Pharmaceuticals and Mosaic Immunoengineerin

Given the investment horizon of 90 days Processa Pharmaceuticals is expected to generate 0.55 times more return on investment than Mosaic Immunoengineerin. However, Processa Pharmaceuticals is 1.82 times less risky than Mosaic Immunoengineerin. It trades about 0.02 of its potential returns per unit of risk. Mosaic Immunoengineering is currently generating about 0.01 per unit of risk. If you would invest  25.00  in Processa Pharmaceuticals on May 1, 2025 and sell it today you would lose (3.00) from holding Processa Pharmaceuticals or give up 12.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Processa Pharmaceuticals  vs.  Mosaic Immunoengineering

Processa Pharmaceuticals

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Processa Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, Processa Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Mosaic Immunoengineering

Risk-Adjusted Performance

Very Weak

Over the last 90 days Mosaic Immunoengineering has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly uncertain primary indicators, Mosaic Immunoengineerin may actually be approaching a critical reversion point that can send shares even higher in August 2025.

Pair Trading with Processa Pharmaceuticals and Mosaic Immunoengineerin

The main advantage of trading using opposite Processa Pharmaceuticals and Mosaic Immunoengineerin positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Processa Pharmaceuticals position performs unexpectedly, Mosaic Immunoengineerin can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mosaic Immunoengineerin will offset losses from the drop in Mosaic Immunoengineerin's long position.

The idea behind Processa Pharmaceuticals and Mosaic Immunoengineering pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.